Centene Corporation
CNCBusiness Overview
ticker: CNC step: 01 generated: 2026-05-12 source: quick-research
Centene Corporation (CNC) — Business Overview
Business Description
Centene Corporation is one of the largest managed care organizations in the United States, operating as a Fortune 50 company that specializes in government-sponsored healthcare programs. Founded in 1984 and headquartered in St. Louis, Missouri, Centene primarily administers Medicaid managed care contracts across 31 states, while also serving Medicare Advantage and ACA Marketplace populations. The company acts as an intermediary between government payers and healthcare providers, earning a spread between premium revenue received and medical costs paid out.
Revenue Model
Centene earns premium revenues from government contracts (Medicaid, Medicare) and marketplace plans, then pays out medical claims to providers. The key profitability metric is the Health Benefits Ratio (HBR) — medical costs as a percentage of premium revenue. An HBR below 86–88% generates operating profit; above that, margins erode. Centene also earns service revenue from specialty subsidiaries (pharmacy benefit management, behavioral health, vision/dental). Revenue is very high in absolute terms ($160B+) but net margins are thin (~2–3%).
Products & Services
- Medicaid Managed Care — Largest business: contracts with 31 states to manage Medicaid populations; ~59% of premium revenue
- Medicare Advantage — Plans for seniors; growing focus segment
- ACA Marketplace Plans — Individual and family health insurance through federal/state exchanges; historically ~$5–6B in premium revenue but contracting sharply in 2026
- Specialty Services — Pharmacy benefit management (Envolve), behavioral health, home health, vision and dental services, and care management programs
Customer Base & Go-to-Market
Centene's primary "customers" are state and federal governments that award multi-year Medicaid managed care contracts. Individual members enroll through state programs or ACA exchanges. With ~13 million Medicaid members and several million Medicare/ACA members, Centene serves predominantly low-income, high-acuity populations. Contract renewals and rate-setting by state Medicaid agencies are the primary commercial lever.
Competitive Position
Centene is one of the top 3 Medicaid managed care companies alongside UnitedHealth Group and Molina Healthcare. Its competitive moat rests on: (1) deep state-by-state relationships and operational expertise in navigating complex Medicaid rules; (2) scale that enables lower administrative costs per member; and (3) a diversified network of specialty subsidiaries. The company has been under pressure since 2023–2025 due to post-COVID Medicaid redeterminations (which reduced membership by ~1.5M) and ACA Marketplace medical cost inflation.
Key Facts
- Founded: 1984
- Headquarters: St. Louis, Missouri
- Employees: ~70,000+
- Exchange: NYSE
- Sector / Industry: Health Care / Managed Health Care
- Market Cap: ~$20–25B (approximate, 2025–2026 after significant stock decline)
Financial Snapshot
ticker: CNC step: 04 generated: 2026-05-12 source: quick-research
Centene Corporation (CNC) — Financial Snapshot
Income Statement Summary
| Metric | FY2022 | FY2023 | FY2024 | YoY |
|---|---|---|---|---|
| Revenue | $144.5B | $154.0B | $163.1B | +6% |
| Health Benefits Ratio (HBR) | ~87.7% | ~87.7% | ~88.5%+ | |
| Operating Margin | ~2.5% | ~2.8% | ~2.7% | |
| Net Income | ~$1.7B | ~$2.7B | $3.3B | +22% |
| EPS (GAAP diluted) | $2.07 | ~$5.00 | ~$6.30 | |
| EPS (adjusted diluted) | $5.78 | ~$7.00+ | ~$7.50 |
Note: FY2025 was highly disrupted — ACA losses and Medicaid HBR pressure caused multiple guidance withdrawals and a large Q4 2025 loss. FY2025 full-year results showed ~$1.5B+ in challenges before partial recovery in Q1 2026.
Cash Flow & Balance Sheet (FY2024)
| Metric | Value |
|---|---|
| Operating Cash Flow | ~$2.3B |
| Free Cash Flow | ~$1.4B |
| Cash & Equivalents | ~$14B |
| Total Debt | ~$18B |
Note: FY2022 FCF was $5.3B and FY2023 was $7.3B — FY2024 decline reflects Medicaid acuity and ACA cost pressures impacting earnings.
Key Ratios (approximate)
- P/E (forward): ~8–10x | P/B: ~1.2x | FCF Yield: ~5–8%
- Revenue Growth (FY2024): +6% | Net Margin: ~2%
Growth Profile
Centene has grown revenue rapidly through Medicaid contract wins and ACA marketplace expansion, but profitability has been highly volatile. The 2023–2025 period was defined by: (1) Medicaid redeterminations removing ~1.5M low-acuity members and raising average acuity/HBR; (2) ACA Marketplace adverse selection as enhanced subsidies fueled enrollment of high-cost members; and (3) state rate increases lagging medical cost inflation. ACA membership has already contracted sharply — from 5.5M at end-2025 to ~3.5M in Q1 2026 (-36%) as subsidy expirations drove healthier enrollees out.
Forward Estimates
- FY2026: Revenue guidance reduced due to ACA membership losses; Medicaid HBR improvement is the key earnings driver; management expects "meaningful margin improvement and renewed adjusted EPS growth" — consensus cautious, Hold rating from 20 analysts
Deeper Financial Analysis
The fundamental tier adds 9 additional research dimensions for $CNC.